12:00 AM
 | 
Jun 05, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Valentis preclinical data

In a mouse model, a single administration of VLTS's EPO gene medicine under the control of its GeneSwitch technology produced...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >